This site is intended for healthcare professionals only
LoginRegister
Around 3000 Himachal Doctors Failed to Renew License to PracticeBreather for D.Pharm Graduates: PCI Grants One-Year Provisional Licenses Amid Exit Exam Delays
BDR Pharmaceutical Gets CDSCO Panel Nod for Bioequivalence Study of Elobixibat tabletBDR Pharmaceutical Gets CDSCO Panel Nod for Bioequivalence Study of Elobixibat tablet
Indoco Remedies secures USFDA approval for Allopurinol Tablets to lower high uric acid levels in bloodSpurious medicines worth Rs 6.60 crore seized in raid at Kolkata premises
Merck, Daiichi Sankyo Ifinatamab deruxtecan granted Breakthrough Therapy Designation by USFDA for pretreated extensive-stage small cell lung cancerMerck gets UK approval for lung disease drug Sotatercept
CDSCO Flags 8 batches of Spurious Medicines, Including Popular Brands Augmentin, PAN 40CDSCO Flags PAN-40, AUGMENTIN Batches as Spurious in November 2024 Alert
Venus Remedies gets GMP certification from Moldova Ministry of Health for antibiotic-carbapenern facilityVenus Remedies gets GMP certification from Moldova Ministry of Health for antibiotic-carbapenern...
Sun Pharma Secures Interim Court Relief In URSOCOL Trademark DisputeSun Pharma to sell 100 percent stake in Japanese arm
Govt Invites Pharma Firms to Submit Data for Ceiling Price ReviewNPPA to Re-Examine Iohexol Injection Price Challenged by JB Chemicals
Roche receives FDA approval for VENTANA MET (SP44) RxDx Assay as Companion Diagnostic in non-small cell lung cancerRoche has no plans for job cuts and business is healthy: CEO
Novartis intrathecal onasemnogene abeparvovec Phase III studyNovartis intrathecal onasemnogene abeparvovec Phase III study meets primary endpoint in children,...
GSK buys IDRx for up to USD 1.15 billionDiabetes treatment: Lupin buys Huminsulin from Eli Lilly
JnJ launches Shockwave Javelin Peripheral IVL Catheter in EuropeEuropean Commission approves Janssen-Cilag International Rybrevant, Lazcluze combo for first-line...
X